Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses.
Parisi SG, Mengoli C, Basso M, Vicenti I, Gatti F, Scaggiante R, Fiaschi L, Giammarino F, Iannetta M, Malagnino V, Zago D, Dragoni F, Zazzi M. Parisi SG, et al. Among authors: iannetta m. Vaccines (Basel). 2022 Aug 2;10(8):1237. doi: 10.3390/vaccines10081237. Vaccines (Basel). 2022. PMID: 36016125 Free PMC article.
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab.
Iannetta M, Cesta N, Stingone C, Malagnino V, Teti E, Vitale P, De Simone G, Rossi B, Ansaldo L, Compagno M, Spalliera I, Di Lorenzo A, Landi D, Nicoletti CG, Marfia GA, Andreoni M, Sarmati L. Iannetta M, et al. Mult Scler Relat Disord. 2020 Oct;45:102442. doi: 10.1016/j.msard.2020.102442. Epub 2020 Aug 4. Mult Scler Relat Disord. 2020. PMID: 32777745 Free PMC article.
Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis.
Scutari R, Piermatteo L, Ciancio Manuelli M, Iannetta M, Salpini R, Bertoli A, Alteri C, Saccomandi P, Bellocchi MC, Malagnino V, Teti E, Sforza D, Siragusa L, Grande M, Sarmati L, Svicher V, Andreoni M, Ceccherini-Silberstein F. Scutari R, et al. Among authors: iannetta m. Life (Basel). 2020 Nov 23;10(11):302. doi: 10.3390/life10110302. Life (Basel). 2020. PMID: 33238410 Free PMC article.
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort.
Malagnino V, Teti E, Compagno M, Coppola L, Salpini R, Svicher V, Basso M, Battagin G, Panese S, Rossi MC, Scaggiante R, Zago D, Iannetta M, Parisi SG, Andreoni M, Sarmati L. Malagnino V, et al. Among authors: iannetta m. Microorganisms. 2021 Feb 15;9(2):396. doi: 10.3390/microorganisms9020396. Microorganisms. 2021. PMID: 33671934 Free PMC article.
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.
Balestrieri E, Minutolo A, Petrone V, Fanelli M, Iannetta M, Malagnino V, Zordan M, Vitale P, Charvet B, Horvat B, Bernardini S, Garaci E, di Francesco P, Sinibaldi Vallebona P, Sarmati L, Grelli S, Andreoni M, Perron H, Matteucci C. Balestrieri E, et al. Among authors: iannetta m. EBioMedicine. 2021 Apr;66:103341. doi: 10.1016/j.ebiom.2021.103341. Epub 2021 Apr 15. EBioMedicine. 2021. PMID: 33867312 Free PMC article.
T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers.
Iannetta M, Landi D, Cola G, Malagnino V, Teti E, Fraboni D, Buccisano F, Grelli S, Coppola L, Campogiani L, Andreoni M, Marfia GA, Sarmati L. Iannetta M, et al. Mult Scler Relat Disord. 2021 Oct;55:103157. doi: 10.1016/j.msard.2021.103157. Epub 2021 Jul 21. Mult Scler Relat Disord. 2021. PMID: 34418737 Free PMC article.
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.
Iannetta M, Landi D, Cola G, Campogiani L, Malagnino V, Teti E, Coppola L, Di Lorenzo A, Fraboni D, Buccisano F, Grelli S, Mozzani M, Zingaropoli MA, Ciardi MR, Nisini R, Bernardini S, Andreoni M, Marfia GA, Sarmati L. Iannetta M, et al. Front Immunol. 2022 Jan 17;12:796482. doi: 10.3389/fimmu.2021.796482. eCollection 2021. Front Immunol. 2022. PMID: 35111162 Free PMC article. Clinical Trial.
In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production.
Imeneo A, Alessio G, Di Lorenzo A, Campogiani L, Lodi A, Barreca F, Zordan M, Barchi V, Massa B, Tedde S, Crea A, Vitale P, Spalliera I, Compagno M, Coppola L, Dori L, Malagnino V, Teti E, Andreoni M, Sarmati L, Iannetta M. Imeneo A, et al. Among authors: iannetta m. Life (Basel). 2022 Feb 7;12(2):244. doi: 10.3390/life12020244. Life (Basel). 2022. PMID: 35207531 Free PMC article.
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020.
Lai A, Bergna A, Toppo S, Morganti M, Menzo S, Ghisetti V, Bruzzone B, Codeluppi M, Fiore V, Rullo EV, Antonelli G, Sarmati L, Brindicci G, Callegaro A, Sagnelli C, Francisci D, Vicenti I, Miola A, Tonon G, Cirillo D, Menozzi I, Caucci S, Cerutti F, Orsi A, Schiavo R, Babudieri S, Nunnari G, Mastroianni CM, Andreoni M, Monno L, Guarneri D, Coppola N, Crisanti A, Galli M, Zehender G; SCIRE-SARS-CoV-2 Italian Research Enterprise-Collaborative Group. Lai A, et al. Sci Rep. 2022 Apr 6;12(1):5736. doi: 10.1038/s41598-022-09738-0. Sci Rep. 2022. PMID: 35388091 Free PMC article.
106 results